Bafna Pharmaceuticals Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Mar '20
Dec '19
Sep '19
Jun '19
Sep '18
Total Qtr Revenue cr
12.46
10.96
12.16
7.15
8.80
Other Income Qtr Cr-0.670.030.590.30-0.03
Operating Revenues Qtr13.1310.9311.576.858.84

*All values are in Cr.

Operating Expenses Qtr
8.89
10.70
11.94
9.72
8.65
Operating Profit Qtr
4.24
0.22
-0.38
-2.87
0.18
EBIDT Qtr Cr
2.73
-21.46
0.22
-2.57
0.15
Depreciation Qtr
0.52
1.00
0.72
1.02
0.75
Net Profit Qtr
0.32
-22.33
-0.59
-2.13
-1.28
Basic EPS Qtr
0.20
-94.39
-0.25
-0.90
-0.80
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -